Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1
暂无分享,去创建一个
K. Yanagihara | D. Sasaki | H. Hasegawa | A. Okayama | S. Fukui | T. Koga | Hideki Nakamura | A. Kawakami | Tatsufumi Nakamura | Y. Endo
[1] K. Ohno-Matsui,et al. In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study , 2020, Frontiers in Microbiology.
[2] K. Eguchi,et al. Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study , 2020, Modern rheumatology.
[3] S. Savic,et al. A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab , 2018, Front. Immunol..
[4] K. Eguchi,et al. Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti–Human T Lymphotropic Virus Type I Antibody–Positive Rheumatoid Arthritis , 2018, Arthritis & rheumatology.
[5] K. Yanagihara,et al. Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy , 2017, BMC Immunology.
[6] T. Naoe,et al. Development of adult T-cell leukemia in a patient with rheumatoid arthritis treated with tocilizumab. , 2013, Internal medicine.
[7] K. Jeang,et al. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy , 2011, Oncogene.
[8] K. Yamaguchi,et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.
[9] M. Hashizume,et al. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. , 2008, Rheumatology.
[10] E. Harhaj,et al. Mechanisms of persistent NF-kappaB activation by HTLV-I tax. , 2005, IUBMB life.
[11] J. Weber,et al. High Circulating Frequencies of Tumor Necrosis Factor Alpha- and Interleukin-2-Secreting Human T-Lymphotropic Virus Type 1 (HTLV-1)-Specific CD4+ T Cells in Patients with HTLV-1-Associated Neurological Disease , 2003, Journal of Virology.
[12] K. Eguchi,et al. Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells. , 1993, The Journal of clinical investigation.
[13] S. Nagataki,et al. Characterization of HTLV-I in a T-cell line established from a patient with myelopathy. , 1989, Archives of neurology.
[14] M. Yoshida,et al. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Reitz,et al. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group , 1982, Nature.
[16] Y. Ohtsuki,et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells , 1981, Nature.